Posted on 12 月 10, 202412/10/24
Association between Targeted Therapy and Survival in Patients with Myelodysplastic Syndromes
Posted on 12 月 9, 202412/9/24
Association Between Targeted Therapy and Survival in Patients With Acute Myeloid Leukemia
Posted on 11 月 26, 202411/26/24
The Importance of Quality-of-Life Metrics in mCRPC
Posted on 11 月 6, 202411/6/24
Adherence Redefined: Evolving Approaches to Adherence in Oncology Clinical Pathways
Posted on 11 月 4, 202411/4/24
Comparing First-Line Treatments for mCRPC: Insights From a Comprehensive NMA
Posted on 9 月 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on 6 月 5, 20246/5/24
FDA Guidance and Considerations for Scientific Exchange Communication Strategies
Posted on 5 月 28, 20245/28/24
Real-World Effectiveness of Treatments Post-CDK4/6i in Treating HR+/HER2- Locally Advanced or Metastatic Breast Cancer
Posted on 3 月 12, 20243/12/24
Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact
Posted on 2 月 19, 20242/19/24